NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute has awarded a consortium of institutions $14.4 million to research better methods of predicting which hypertrophic cardiomyopathy patients are at the highest risk of heart failure or sudden death.

The University of Virginia School of Medicine and the University of Oxford in the UK, will direct the five-year study which will follow 2,750 patients for up to five years. The study will be conducted at 35 to 40 sites in the US, Canada, and Europe, including the UK, Italy and Germany.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: omic analysis of permafrost microbes, hookworm genome, and more.

Biologists turn to environmental DNA sampling to determine whether elusive or invasive species are shedding DNA in a given area.

Rob Knight writes at Scientific American that microbiome studies are about to break out of the laboratory.

Harold Varmus, the director of the National Cancer Institute, has announced that he is stepping down after nearly five years.